Number of the records: 1  

Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis

  1. 1.
    SYSNO ASEP0368248
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleMesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis
    Author(s) Forostyak, Serhiy (UEM-P) RID, ORCID
    Jendelová, Pavla (UEM-P) RID, ORCID
    Kapcalová, Miroslava (UEM-P)
    Arboleda Toro, David (UEM-P)
    Syková, Eva (UEM-P) RID
    Source TitleCytotherapy. - : Elsevier - ISSN 1465-3249
    Roč. 13, č. 9 (2011), s. 1036-1046
    Number of pages11 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsmotor neurons ; neurodegenerative diseases ; stem cells
    Subject RIVFH - Neurology
    R&D ProjectsLC554 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    GAP304/11/0189 GA ČR - Czech Science Foundation (CSF)
    CEZAV0Z50390703 - UEM-P (2007-2013)
    UT WOS000294904300003
    DOI10.3109/14653249.2011.592521
    AnnotationIn current study transgenic rats overexpressing mutant human SOD1 were used as a model of fALS. We have found that grafting of MSC into symptomatic rats had a significant effect on motor activity and grip strength and longer lifespan if compared with the control group of animals. Transplanted cells survived and migrated in the spinal cord until the end stage of the disease without any side effects. Combined delivery of BM-derived MSC, therefore, could be an attractive approach for bench-to bedside studies in the treatment of ALS.
    WorkplaceInstitute of Experimental Medicine
    ContactLenka Koželská, lenka.kozelska@iem.cas.cz, Tel.: 241 062 218, 296 442 218
    Year of Publishing2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.